Omata M - Search Results

1

Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model.

Kunimasa K, Hirotsu Y, Nakamura H, Tamiya M, Iijima Y, Ishida H, Hamamoto Y, Maniwa T, Kimura T, Nishino K, Goto T, Amemiya K, Mochizuki H, Oyama T, Nakatsuka SI, Kumagai T, Okami J, Higashiyama M, Imamura F, Omata M. Kunimasa K, et al. Among authors: omata m. Cancer Genet. 2020 Feb;241:51-56. doi: 10.1016/j.cancergen.2019.12.006. Epub 2019 Dec 25. Cancer Genet. 2020. PMID: 31917104

2

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Shiratori Y, et al. Among authors: omata m. Cancer. 1997 Dec 1;80(11):2060-7. Cancer. 1997. PMID: 9392327

3

Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.

Hamamura K, Shiratori Y, Shiina S, Imamura M, Obi S, Sato S, Yoshida H, Omata M. Hamamura K, et al. Among authors: omata m. Cancer. 2000 Apr 1;88(7):1557-64. doi: 10.1002/(sici)1097-0142(20000401)88:7<1557::aid-cncr9>3.0.co;2-g. Cancer. 2000. PMID: 10738213

4

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Yoshida H, Shiina S, Omata M. Koike Y, et al. Among authors: omata m. Cancer. 2001 Feb 1;91(3):561-9. doi: 10.1002/1097-0142(20010201)91:3<561::aid-cncr1035>3.0.co;2-n. Cancer. 2001. PMID: 11169939

5

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.

Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M. Tateishi R, et al. Among authors: omata m. Cancer. 2005 Mar 15;103(6):1201-9. doi: 10.1002/cncr.20892. Cancer. 2005. PMID: 15690326 Free article.

6

Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors.

Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, Goto T, Omata M, Yoshida H, Koike K. Uchino K, et al. Among authors: omata m. Cancer. 2011 Oct 1;117(19):4475-83. doi: 10.1002/cncr.25960. Epub 2011 Mar 22. Cancer. 2011. PMID: 21437884 Free article.

7

Factors contributing to the overall survival in patients with hepatocellular carcinoma treated by sorafenib.

Tsukui Y, Mochizuki H, Hoshino Y, Kawakami S, Kuno T, Fukasawa Y, Iwamoto F, Hirose S, Yoshida T, Hosoda K, Suzuki Y, Hosoda K, Kojima Y, Hirose Y, Shindou K, Matsuda M, Yagawa S, Tawara A, Kobayashi M, Konishi T, Yamazaki T, Takahashi S, Fuji H, Enomoto N, Omata M. Tsukui Y, et al. Among authors: omata m. Hepatogastroenterology. 2012 Nov-Dec;59(120):2536-9. doi: 10.5754/hge12059. Hepatogastroenterology. 2012. PMID: 22497953

8

HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b.

Hirotsu Y, Kanda T, Matsumura H, Moriyama M, Yokosuka O, Omata M. Hirotsu Y, et al. Among authors: omata m. Hepatol Int. 2015 Jul;9(3):424-30. doi: 10.1007/s12072-015-9624-2. Epub 2015 Mar 20. Hepatol Int. 2015. PMID: 25791176

9

Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing.

Hirotsu Y, Nakagomi H, Sakamoto I, Amemiya K, Mochizuki H, Omata M. Hirotsu Y, et al. Among authors: omata m. Mol Genet Genomic Med. 2015 Mar;3(2):121-9. doi: 10.1002/mgg3.120. Epub 2014 Dec 4. Mol Genet Genomic Med. 2015. PMID: 25802882 Free PMC article.

10

Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of expenses.

Nakagomi H, Sakamoto I, Hirotsu Y, Amemiya K, Mochizuki H, Inoue M, Nakagomi S, Kubota T, Omata M. Nakagomi H, et al. Among authors: omata m. Breast Cancer. 2016 Jul;23(4):649-53. doi: 10.1007/s12282-015-0618-7. Epub 2015 May 30. Breast Cancer. 2016. PMID: 26025266

11

Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer.

Nakagomi H, Sakamoto I, Hirotsu Y, Amemiya K, Mochiduki H, Omata M. Nakagomi H, et al. Among authors: omata m. Int J Clin Oncol. 2016 Apr;21(2):270-275. doi: 10.1007/s10147-015-0906-4. Epub 2015 Sep 28. Int J Clin Oncol. 2016. PMID: 26411315

12

Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer.

Hirotsu Y, Nakagomi H, Sakamoto I, Amemiya K, Oyama T, Mochizuki H, Omata M. Hirotsu Y, et al. Among authors: omata m. Mol Genet Genomic Med. 2015 Sep;3(5):459-66. doi: 10.1002/mgg3.157. Epub 2015 May 12. Mol Genet Genomic Med. 2015. PMID: 26436112 Free PMC article.

13

BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.

Sakamoto I, Hirotsu Y, Nakagomi H, Ouchi H, Ikegami A, Teramoto K, Amemiya K, Mochizuki H, Omata M. Sakamoto I, et al. Among authors: omata m. Cancer. 2016 Jan 1;122(1):84-90. doi: 10.1002/cncr.29707. Epub 2015 Oct 6. Cancer. 2016. PMID: 26439132 Free article.

14

Targeted and exome sequencing identified somatic mutations in hepatocellular carcinoma.

Hirotsu Y, Zheng TH, Amemiya K, Mochizuki H, Guleng B, Omata M. Hirotsu Y, et al. Among authors: omata m. Hepatol Res. 2016 Oct;46(11):1145-1151. doi: 10.1111/hepr.12663. Epub 2016 Mar 15. Hepatol Res. 2016. PMID: 26850916

15

Analysis of tumor-derived DNA in plasma and bone marrow fluid in lung cancer patients.

Goto T, Hirotsu Y, Oyama T, Amemiya K, Omata M. Goto T, et al. Among authors: omata m. Med Oncol. 2016 Mar;33(3):29. doi: 10.1007/s12032-016-0744-x. Epub 2016 Feb 20. Med Oncol. 2016. PMID: 26897174

16

Report of a case with T1a gallbladder poorly differentiated adenocarcinoma, solid type, which developed into lymph node metastases.

Takano A, Harai S, Nakagomi H, Maruyama M, Yamamoto A, Watanabe H, Nakada H, Furuya K, Hada M, Miyasaka Y, Oyama T, Omata M. Takano A, et al. Among authors: omata m. Surg Case Rep. 2015 Dec;1(1):116. doi: 10.1186/s40792-015-0117-2. Epub 2015 Nov 16. Surg Case Rep. 2015. PMID: 26943440 Free PMC article.

17

Report of a case with a spontaneous mesenteric hematoma that ruptured into the small intestine.

Shikata D, Nakagomi H, Takano A, Nakagomi T, Watanabe H, Maruyama M, Nakada H, Yamamoto A, Furuya K, Hada M, Miyasaka Y, Omata M, Oyama T. Shikata D, et al. Among authors: omata m. Int J Surg Case Rep. 2016;24:124-7. doi: 10.1016/j.ijscr.2016.05.034. Epub 2016 May 24. Int J Surg Case Rep. 2016. PMID: 27239790 Free PMC article.

18

A study of tumor heterogeneity in a case with breast cancer.

Nakada H, Nakagomi H, Hirotsu Y, Amemiya K, Mochizuki H, Inoue M, Oyama T, Omata M. Nakada H, et al. Among authors: omata m. Breast Cancer. 2017 May;24(3):483-489. doi: 10.1007/s12282-016-0733-0. Epub 2016 Sep 29. Breast Cancer. 2017. PMID: 27687626

19

Pseudo-Meigs' syndrome due to ovarian metastases from colon cancer: a case report and review of the literature.

Yamamoto A, Miyasaka Y, Furuya K, Watanabe H, Maruyama M, Nakada H, Takano A, Hada M, Nakagomi H, Omata M, Oyama T. Yamamoto A, et al. Among authors: omata m. Surg Case Rep. 2016 Dec;2(1):112. doi: 10.1186/s40792-016-0209-7. Epub 2016 Oct 12. Surg Case Rep. 2016. PMID: 27734419 Free PMC article.

20

Touch imprint cytology with massively parallel sequencing (TIC-seq): a simple and rapid method to snapshot genetic alterations in tumors.

Amemiya K, Hirotsu Y, Goto T, Nakagomi H, Mochizuki H, Oyama T, Omata M. Amemiya K, et al. Among authors: omata m. Cancer Med. 2016 Dec;5(12):3426-3436. doi: 10.1002/cam4.950. Epub 2016 Oct 24. Cancer Med. 2016. PMID: 27774772 Free PMC article.

21

Report of a case with gallbladder carcinoma: P53 expression of the peritumor epithelium might predict biliary tract recurrence.

Takano A, Nakagomi H, Ikegame K, Yamamoto A, Watanabe H, Nakada H, Inoue M, Sugai H, Yasutome M, Furuya K, Hada M, Miyasaka Y, Oyama T, Omata M. Takano A, et al. Among authors: omata m. Int J Surg Case Rep. 2016;28:325-329. doi: 10.1016/j.ijscr.2016.10.042. Epub 2016 Oct 18. Int J Surg Case Rep. 2016. PMID: 27776323 Free PMC article.

22

Comparison between two amplicon-based sequencing panels of different scales in the detection of somatic mutations associated with gastric cancer.

Hirotsu Y, Kojima Y, Okimoto K, Amemiya K, Mochizuki H, Omata M. Hirotsu Y, et al. Among authors: omata m. BMC Genomics. 2016 Oct 26;17(1):833. doi: 10.1186/s12864-016-3166-4. BMC Genomics. 2016. PMID: 27782820 Free PMC article.

23

Intrinsic HER2 V777L mutation mediates resistance to trastuzumab in a breast cancer patient.

Hirotsu Y, Nakagomi H, Amemiya K, Oyama T, Inoue M, Mochizuki H, Omata M. Hirotsu Y, et al. Among authors: omata m. Med Oncol. 2017 Jan;34(1):3. doi: 10.1007/s12032-016-0857-2. Epub 2016 Nov 29. Med Oncol. 2017. PMID: 27900589

24

Rapid Changes in Circulating Tumor DNA in Serially Sampled Plasma During Treatment of Breast Cancer: A Case Report.

Nakagomi H, Hirotsu Y, Amemiya K, Nakada H, Inoue M, Mochizuki H, Oyama T, Omata M. Nakagomi H, et al. Among authors: omata m. Am J Case Rep. 2017 Jan 9;18:26-32. doi: 10.12659/ajcr.901295. Am J Case Rep. 2017. PMID: 28065930 Free PMC article.

25

Stepwise addition of genetic changes correlated with histological change from "well-differentiated" to "sarcomatoid" phenotypes: a case report.

Goto T, Hirotsu Y, Mochizuki H, Nakagomi T, Oyama T, Amemiya K, Omata M. Goto T, et al. Among authors: omata m. BMC Cancer. 2017 Jan 19;17(1):65. doi: 10.1186/s12885-017-3059-1. BMC Cancer. 2017. PMID: 28103823 Free PMC article.

26

Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.

Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H, Omata M, Oyama T. Inoue M, et al. Among authors: omata m. Breast Cancer. 2017 Sep;24(5):667-672. doi: 10.1007/s12282-017-0753-4. Epub 2017 Jan 20. Breast Cancer. 2017. PMID: 28108967

27

Analysis of significantly mutated genes as a clinical tool for the diagnosis in a case of lung cancer.

Miyashita Y, Hirotsu Y, Tsutsui T, Higashi S, Sogami Y, Kakizaki Y, Goto T, Amemiya K, Oyama T, Omata M. Miyashita Y, et al. Among authors: omata m. Respir Med Case Rep. 2017 Feb 17;20:171-175. doi: 10.1016/j.rmcr.2017.02.008. eCollection 2017. Respir Med Case Rep. 2017. PMID: 28275538 Free PMC article.

28

PALB2 mutation in a woman with bilateral breast cancer: A case report.

Nakagomi H, Hirotsu Y, Okimoto K, Sakamoto I, Amemiya K, Nakagomi S, Kubota T, Mochizuki H, Omata M. Nakagomi H, et al. Among authors: omata m. Mol Clin Oncol. 2017 Apr;6(4):556-560. doi: 10.3892/mco.2017.1189. Epub 2017 Mar 9. Mol Clin Oncol. 2017. PMID: 28413668 Free PMC article.

29

Mutational analysis of multiple lung cancers: Discrimination between primary and metastatic lung cancers by genomic profile.

Goto T, Hirotsu Y, Mochizuki H, Nakagomi T, Shikata D, Yokoyama Y, Oyama T, Amemiya K, Okimoto K, Omata M. Goto T, et al. Among authors: omata m. Oncotarget. 2017 May 9;8(19):31133-31143. doi: 10.18632/oncotarget.16096. Oncotarget. 2017. PMID: 28415711 Free PMC article.

30

Unexpectedly low frequency of BRCA1/2 deleterious mutations in Japanese patients with breast cancer.

Sakamoto I, Nakagomi H, Okimoto K, Inoue M, Hirotsu Y, Amemiya K, Mochizuki H, Omata M. Sakamoto I, et al. Among authors: omata m. Breast J. 2018 Jan;24(1):96-98. doi: 10.1111/tbj.12849. Epub 2017 Jun 8. Breast J. 2018. PMID: 28597494 No abstract available.

31

Rapid decrease of circulating tumor DNA predicted the treatment effect of nivolumab in a lung cancer patient within only 5 days.

Iijima Y, Hirotsu Y, Amemiya K, Higashi S, Miyashita Y, Omata M. Iijima Y, et al. Among authors: omata m. Respir Med Case Rep. 2017 Jun 5;22:31-33. doi: 10.1016/j.rmcr.2017.05.015. eCollection 2017. Respir Med Case Rep. 2017. PMID: 28649487 Free PMC article.

32

Elucidation of radiation-resistant clones by a serial study of intratumor heterogeneity before and after stereotactic radiotherapy in lung cancer.

Nakagomi T, Goto T, Hirotsu Y, Shikata D, Amemiya K, Oyama T, Mochizuki H, Omata M. Nakagomi T, et al. Among authors: omata m. J Thorac Dis. 2017 Jul;9(7):E598-E604. doi: 10.21037/jtd.2017.06.02. J Thorac Dis. 2017. PMID: 28840024 Free PMC article.

33

Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral blood.

Goto T, Hirotsu Y, Amemiya K, Nakagomi T, Shikata D, Yokoyama Y, Okimoto K, Oyama T, Mochizuki H, Omata M. Goto T, et al. Among authors: omata m. Oncotarget. 2017 Jul 25;8(35):59268-59281. doi: 10.18632/oncotarget.19538. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938635 Free PMC article.

34

Very early response of circulating tumour-derived DNA in plasma predicts efficacy of nivolumab treatment in patients with non-small cell lung cancer.

Iijima Y, Hirotsu Y, Amemiya K, Ooka Y, Mochizuki H, Oyama T, Nakagomi T, Uchida Y, Kobayashi Y, Tsutsui T, Kakizaki Y, Goto T, Miyashita Y, Omata M. Iijima Y, et al. Among authors: omata m. Eur J Cancer. 2017 Nov;86:349-357. doi: 10.1016/j.ejca.2017.09.004. Epub 2017 Nov 5. Eur J Cancer. 2017. PMID: 29078173

35

Genetic basis of a common tumor origin in the development of pancreatic mixed acinar-neuroendocrine-ductal carcinoma: A case report.

Takano A, Hirotsu Y, Amemiya K, Nakagomi H, Oishi N, Oyama T, Mochizuki H, Omata M. Takano A, et al. Among authors: omata m. Oncol Lett. 2017 Oct;14(4):4428-4432. doi: 10.3892/ol.2017.6786. Epub 2017 Aug 22. Oncol Lett. 2017. PMID: 29085438 Free PMC article.

36

Detection of tumor-derived DNA dispersed in the airway improves the diagnostic accuracy of bronchoscopy for lung cancer.

Goto T, Hirotsu Y, Nakagomi T, Shikata D, Yokoyama Y, Amemiya K, Tsutsui T, Kakizaki Y, Oyama T, Mochizuki H, Miyashita Y, Omata M. Goto T, et al. Among authors: omata m. Oncotarget. 2017 May 24;8(45):79404-79413. doi: 10.18632/oncotarget.18159. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108319 Free PMC article.

37

Combined annotation-dependent depletion score for BRCA1/2 variants in patients with breast and/or ovarian cancer.

Nakagomi H, Mochizuki H, Inoue M, Hirotsu Y, Amemiya K, Sakamoto I, Nakagomi S, Kubota T, Omata M. Nakagomi H, et al. Among authors: omata m. Cancer Sci. 2018 Feb;109(2):453-461. doi: 10.1111/cas.13464. Epub 2018 Jan 17. Cancer Sci. 2018. PMID: 29215753 Free PMC article.

38

Simultaneous detection of genetic and copy number alterations in BRCA1/2 genes.

Hirotsu Y, Ooka Y, Sakamoto I, Nakagomi H, Omata M. Hirotsu Y, et al. Among authors: omata m. Oncotarget. 2017 Dec 6;8(70):114463-114473. doi: 10.18632/oncotarget.22962. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383094 Free PMC article.

39

Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines.

Kojima Y, Hirotsu Y, Omata W, Sugimori M, Takaoka S, Ashizawa H, Nakagomi K, Yoshimura D, Hosoda K, Suzuki Y, Mochizuki H, Omata M. Kojima Y, et al. Among authors: omata w, omata m. World J Gastroenterol. 2018 Jan 28;24(4):511-518. doi: 10.3748/wjg.v24.i4.511. World J Gastroenterol. 2018. PMID: 29398872 Free PMC article.

40

New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profiles.

Nakagomi T, Goto T, Hirotsu Y, Shikata D, Yokoyama Y, Higuchi R, Amemiya K, Okimoto K, Oyama T, Mochizuki H, Omata M. Nakagomi T, et al. Among authors: omata m. Oncotarget. 2018 Jan 31;9(12):10635-10649. doi: 10.18632/oncotarget.24365. eCollection 2018 Feb 13. Oncotarget. 2018. PMID: 29535832 Free PMC article.

41

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology.

Amemiya K, Hirotsu Y, Oyama T, Omata M. Amemiya K, et al. Among authors: omata m. J Vis Exp. 2018 Mar 21;(133):56943. doi: 10.3791/56943. J Vis Exp. 2018. PMID: 29630047 Free PMC article.

42

Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach.

Goto T, Hirotsu Y, Amemiya K, Mochizuki H, Omata M. Goto T, et al. Among authors: omata m. Cancers (Basel). 2018 Jun 22;10(7):212. doi: 10.3390/cancers10070212. Cancers (Basel). 2018. PMID: 29932159 Free PMC article. Review.

43

Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.

Iijima Y, Hirotsu Y, Mochizuki H, Amemiya K, Oyama T, Uchida Y, Kobayashi Y, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M. Iijima Y, et al. Among authors: omata m. Clin Lung Cancer. 2018 Nov;19(6):e843-e847. doi: 10.1016/j.cllc.2018.07.002. Epub 2018 Jul 26. Clin Lung Cancer. 2018. PMID: 30122430 No abstract available.

44

Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection.

Ooka Y, Miho K, Shuntaro O, Nakamura M, Ogasawara S, Suzuki E, Yasui S, Chiba T, Arai M, Kanda T, Maruyama H, Yokosuka O, Kato N, Mochizuki H, Omata M. Ooka Y, et al. Among authors: omata m. Hepatol Int. 2018 Nov;12(6):523-530. doi: 10.1007/s12072-018-9895-5. Epub 2018 Sep 21. Hepatol Int. 2018. PMID: 30242733

45

Relationship between formalin reagent and success rate of targeted sequencing analysis using formalin fixed paraffin embedded tissues.

Amemiya K, Hirotsu Y, Oyama T, Omata M. Amemiya K, et al. Among authors: omata m. Clin Chim Acta. 2019 Jan;488:129-134. doi: 10.1016/j.cca.2018.11.002. Epub 2018 Nov 3. Clin Chim Acta. 2019. PMID: 30395866

46

Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3.

Nakagomi T, Goto T, Hirotsu Y, Shikata D, Yokoyama Y, Higuchi R, Otake S, Amemiya K, Oyama T, Mochizuki H, Omata M. Nakagomi T, et al. Among authors: omata m. Cancers (Basel). 2018 Nov 30;10(12):478. doi: 10.3390/cancers10120478. Cancers (Basel). 2018. PMID: 30513627 Free PMC article.

47

Durable response by olaparib for a Japanese patient with primary peritoneal cancer with multiple brain metastases: A case report.

Sakamoto I, Hirotsu Y, Nakagomi H, Ikegami A, Teramoto K, Omata M. Sakamoto I, et al. Among authors: omata m. J Obstet Gynaecol Res. 2019 Mar;45(3):743-747. doi: 10.1111/jog.13851. Epub 2018 Nov 22. J Obstet Gynaecol Res. 2019. PMID: 30565790

48

Molecular subtype switching in early-stage gastric cancers with multiple occurrences.

Takaoka S, Hirotsu Y, Ohyama H, Mochizuki H, Amemiya K, Oyama T, Ashizawa H, Yoshimura D, Nakagomi K, Hosoda K, Suzuki Y, Kojima Y, Omata M. Takaoka S, et al. Among authors: omata m. J Gastroenterol. 2019 Aug;54(8):674-686. doi: 10.1007/s00535-019-01547-z. Epub 2019 Jan 21. J Gastroenterol. 2019. PMID: 30666417

49

Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer.

Hirotsu Y, Mochizuki H, Amemiya K, Ohyama H, Yoshimura D, Amano H, Miura Y, Ashizawa H, Nakagomi K, Takaoka S, Hosoda K, Suzuki Y, Oyama T, Hada M, Kojima Y, Omata M. Hirotsu Y, et al. Among authors: omata m. Med Oncol. 2019 Jan 29;36(3):23. doi: 10.1007/s12032-019-1246-4. Med Oncol. 2019. PMID: 30694393

50

Validation of Tokyo Guideline 2013 as Treatment of Acute Cholecystitis by Real World Data.

Harai S, Mochizuki H, Kojima Y, Nakagomi K, Yoshimura D, Takaoka S, Hosoda K, Suzuki Y, Omata M. Harai S, et al. Among authors: omata m. Dig Dis. 2019;37(4):303-308. doi: 10.1159/000496738. Epub 2019 Feb 7. Dig Dis. 2019. PMID: 30731461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,290 results

Search Page